Mission Statement, Vision, & Core Values (2026) of Siemens Healthineers AG.

As a global leader in medical technology, Siemens Healthineers AG brings together diagnostic imaging, laboratory diagnostics and digital health services across more than 70 countries, powered by approximately 74,000 employees and a strategic identity forged when it became a standalone company in 2018; with Siemens AG announcing in November 2025 a planned reduction of its stake from 67% to 37% and the company weighing a potential diagnostics divestment by 2030, Siemens Healthineers continues to invest heavily in innovation-allocating over $900 million annually in U.S. R&D-while pursuing a mission to enable providers to increase value by expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare, a vision to pioneer breakthroughs for everyone, everywhere, sustainably, and a set of core values-'We listen first,' 'We win together,' 'We learn passionately,' 'We step boldly,' and 'We own it'-that drive collaborative, accountable and bold progress in meeting global healthcare challenges.

Siemens Healthineers AG (0PMJ.L) - Intro

• Siemens Healthineers AG is a global leader in medical technology with a comprehensive portfolio spanning diagnostic imaging, laboratory diagnostics, and digital health services.
• Operations span over 70 countries with approximately 74,000 employees focused on advancing healthcare delivery worldwide.
• Established as a standalone publicly listed entity in 2018, the company has emphasized innovation, partnerships, and sustainability to address global healthcare challenges.
• Governance and ownership evolution: in November 2025 Siemens AG announced a planned reduction of its stake from 67% to 37% via distribution of shares to Siemens AG shareholders to enhance Siemens Healthineers' independence and strategic focus.
• Strategic portfolio review: management is evaluating options including potential divestment or spin-off of the diagnostics division by 2030 to sharpen strategic priorities and capital allocation.
• R&D commitment: the company invests heavily in research and development, with more than $900 million allocated annually in the United States alone.

• Deliver technologies and services that improve patient outcomes and productivity across care settings.
• Enable precision medicine through diagnostics, imaging, and data-driven care pathways.
• Support providers globally with scalable, reliable solutions that reduce costs and increase access.

• To be the trusted partner for healthcare transformation by integrating advanced imaging, diagnostics, and digital solutions into seamless care journeys.
• Drive a future where timely, accurate diagnosis and efficient care delivery are accessible to more patients worldwide.

• Innovation: sustained investment in R&D and breakthrough technologies.
• Quality & Reliability: delivering clinically validated, robust products and services.
• Patient-centeredness: prioritizing outcomes and safety in every solution.
• Collaboration: partnering with healthcare providers, payers, and tech partners.
• Sustainability & Responsibility: integrating environmental, social, and governance principles into operations and strategy.

• Innovation and R&D scaling - maintain and grow multi-hundred-million-dollar annual investments, including >$900M/year in the U.S.
• Digital transformation - expand cloud-enabled diagnostics, AI-driven imaging, and data services to drive recurring revenue and tighter care integration.
• Portfolio optimization - evaluate structural changes (e.g., diagnostics spin-off/divestment by 2030) to sharpen capital focus.
• Independence and governance - implement Siemens AG stake reduction to 37% (announced Nov 2025) and strengthen standalone corporate governance.

Siemens Healthineers AG (0PMJ.L) - Overview

Siemens Healthineers' mission is to enable healthcare providers to increase value by empowering them on the journey towards expanding precision medicine, transforming care delivery, and improving patient experience, all enabled by digitalizing healthcare. This mission underscores the company's commitment to improving outcomes through technological innovation, tailored treatment pathways, and system-wide digital transformation.

• Precision medicine: targeted diagnostics and therapeutics to improve patient outcomes and reduce unnecessary treatments.
• Transforming care delivery: workflow optimization, point-of-care solutions, and integrated care pathways to increase capacity and reduce costs.
• Improving patient experience: patient-centric diagnostics, shorter turnaround times, and minimally invasive imaging/interventions.
• Digitalization: cloud-enabled platforms, AI-driven diagnostics, and interoperability to drive data-driven decision making.

Key strategic pillars directly tied to the mission

• Clinical innovation - expanding modalities in imaging, laboratory diagnostics, and therapy delivery.
• AI & software - embedding machine learning in diagnostic workflows and operational analytics.
• Service & lifecycle management - improving uptime and total cost of ownership for provider customers.
• Partnerships & value-based care models - aligning with payers and provider networks to demonstrate outcome improvements.

How mission translates into measurable outcomes and initiatives

• Precision diagnostics: expanding molecular & immunoassay portfolios to enable personalized therapy selection and reduce trial-and-error prescribing.
• Digital platforms: offering enterprise imaging, diagnostics informatics, and AI toolsets to shorten clinical decision loops and standardize care.
• Operational impact: using remote monitoring and predictive maintenance to increase equipment uptime and lower provider operational costs.
• Patient-centered metrics: reducing diagnostic turnaround time and enhancing throughput in radiology and labs to improve patient satisfaction and outcomes.

For a focused financial breakdown and investor-oriented analysis, see Breaking Down Siemens Healthineers AG Financial Health: Key Insights for Investors

Siemens Healthineers AG (0PMJ.L) Mission Statement

• Leadership in medical-technology innovation: sustained R&D investment and product launches across imaging, diagnostics, and advanced therapies.
• Accessibility "for everyone, everywhere": global footprint and targeted programs to improve care delivery in emerging and underserved markets.
• Sustainability commitment: reducing environmental footprint across manufacturing, supply chain, and product life cycles.

• Product innovation pipeline focused on AI-enabled imaging, point-of-care diagnostics, and minimally invasive therapy systems.
• Global access programs and partnership models to deploy scalable solutions in low- and middle-income countries.
• Operational sustainability: energy-efficient plants, green procurement, and extended product life-cycle services to lower total environmental impact.

• Strong balance sheet and cash generation capacity to fund acquisitions, strategic investments, and R&D.
• Divisional mix (Imaging, Diagnostics, Advanced Therapies, Services) provides diversified revenue streams to support global expansion.
• Active M&A and alliance strategy to broaden technologies and market access while accelerating time-to-market for innovations.

Siemens Healthineers AG (0PMJ.L) - Vision Statement

• We listen first - prioritizing deep understanding of patient and customer needs to design effective solutions and improve clinical workflows.
• We win together - fostering cross-functional collaboration across imaging, diagnostics, therapy, and digital services to deliver end-to-end care improvements.
• We learn passionately - investing in continuous learning and evidence generation to fuel innovation and safer, more effective products.
• We step boldly - embracing disruptive technologies and novel business models (e.g., AI, point-of-care testing, value-based care partnerships) to expand what's possible in healthcare.
• We own it - taking accountability for clinical outcomes, regulatory compliance, and financial performance to earn trust across stakeholders.

• We listen first - Customer co-creation programs and real-world evidence studies guiding product design and reimbursement strategies.
• We win together - Cross-divisional bundled solutions (imaging + lab + digital) deployed in health systems to reduce length-of-stay and improve diagnostic throughput.
• We learn passionately - Clinical education academies and data-science partnerships to validate AI algorithms and train clinicians.
• We step boldly - Investments in AI diagnostics, point-of-care testing expansion, and subscription-based service models to enter new care settings.
• We own it - Quality management and regulatory compliance programs ensuring product safety and long-term customer commitments.

• Recurring revenues and service contracts stabilize cash flows and increase lifetime customer value.
• R&D intensity (~6-7% of revenue) sustains a pipeline that differentiates clinically and commercially.
• Portfolio diversification across imaging, diagnostics, and digital reduces exposure to single-market cycles.